OGD/OND system will help share reviews
Executive Summary
The Office of Generic Drugs is adopting a new information technology system that will enable it to share reviews with the Office of New Drugs, allowing both offices "full access to all available information of approved drug products," FDA announces Oct. 6. The new electronic Division File System provides OGD "document management, tracking, archiving, and electronic signature capabilities for internally generated review documents and search and retrieval capabilities for final versions of internally generated documents." FDA hopes the improved electronic repository for ANDA review and regulatory documents will improve the efficiency of the generic review process; OGD's mounting application backlog has come under fire over the last year (1"The Pink Sheet" Feb. 13, 2006, p. 7)...
You may also be interested in...
Generic Drug Reviews Take A Hit In FDA 2007 Budget Request
FDA is reducing the percentage of generic drug applications for which it aims to shorten review time
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.